Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) Director Yong-Jun Huh bought 2,083,332 shares of Artiva Biotherapeutics stock in a transaction dated Monday, July 22nd. The stock was acquired at an average cost of $12.00 per share, for a total transaction of $24,999,984.00. Following the completion of the acquisition, the director now directly owns 3,306,900 shares in the company, valued at $39,682,800. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Artiva Biotherapeutics Trading Down 1.7 %
Shares of ARTV opened at $11.80 on Thursday. Artiva Biotherapeutics, Inc. has a 52-week low of $11.71 and a 52-week high of $16.00.
Recommended Stories
- Five stocks we like better than Artiva Biotherapeutics
- What is a Stock Market Index and How Do You Use Them?
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- Top Stocks Investing in 5G Technology
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- When to Sell a Stock for Profit or Loss
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Receive News & Ratings for Artiva Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artiva Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
